ORAL ANTIVIRAL AGENTS REDUCE THE RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B: SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Singal, Ashwani K. [1 ]
Fontana, Robert J. [2 ]
机构：
[1] Univ Texas Med Branch, Galveston, TX USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1016A / 1016A
页数：1
相关论文
共 50 条
  • [41] Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta-analysis
    Gu, Lihu
    Yao, Qigu
    Shen, Zefeng
    He, Ying
    Ng, Derry Minyao
    Yang, Tong
    Chen, Bangsheng
    Chen, Ping
    Mao, Feiyan
    Yu, Qili
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (09) : 1467 - 1476
  • [42] Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis
    Dave, Shravan
    Park, Sooyoung
    Murad, M. Hassan
    Barnard, Abbey
    Prokop, Larry
    Adams, Leon A.
    Singh, Siddharth
    Loomba, Rohit
    HEPATOLOGY, 2021, 73 (01) : 68 - 78
  • [43] Hepatitis E virus infection and risk of hepatocellular carcinoma: A systematic review and meta-analysis
    Yin, Xia
    Kan, Fanggong
    CANCER EPIDEMIOLOGY, 2023, 87
  • [44] Systematic review with meta-analysis: effectiveness of direct-acting antiviral treatment for hepatitis C in patients with hepatocellular carcinoma
    He, Sichan
    Lockart, Ian
    Alavi, Maryam
    Danta, Mark
    Hajarizadeh, Behzad
    Dore, Gregory J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (01) : 34 - 52
  • [45] Entecavir vs Tenofovir in Hepatocellular Carcinoma Prevention in Chronic Hepatitis B Infection: A Systematic Review and Meta-Analysis
    Cheung, Ka Shing
    Mak, Lung Yi
    Liu, Sze Hang
    Cheng, Ho Ming
    Seto, Wai Kay
    Yuen, Man Fung
    Lai, Ching Lung
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2020, 11 (10) : e00236
  • [46] Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis
    Ji, Fanpu
    Yeo, Yee Hui
    Wei, Mike Tzuhen
    Ogawa, Eiichi
    Enomoto, Masaru
    Lee, Dong Hyun
    Iio, Etsuko
    Lubel, John
    Wang, Wenjun
    Wei, Bin
    Ide, Tatsuya
    Preda, Carmen Monica
    Conti, Fabio
    Minami, Tatsuya
    Bielen, Rob
    Sezaki, Hitomi
    Barone, Michele
    Kolly, Philippe
    Chu, Po-sung
    Virlogeux, Victor
    Eurich, Dennis
    Henry, Linda
    Bass, Michelle B.
    Kanai, Takanori
    Dang, Shuangsuo
    Li, Zongfang
    Dufour, Jean-Francois
    Zoulim, Fabien
    Andreone, Pietro
    Cheung, Ramsey C.
    Tanaka, Yasuhito
    Furusyo, Norihiro
    Toyoda, Hidenori
    Tamori, Akihiro
    Nguyen, Mindie H.
    JOURNAL OF HEPATOLOGY, 2019, 71 (03) : 473 - 485
  • [47] Effect of metabolic dysfunction-associated fatty liver disease on the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A systematic review and meta-analysis
    Shen, Sixing
    Pan, Lingyan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 27 (03)
  • [48] Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B
    Tziomalos, Konstantinos
    WORLD JOURNAL OF HEPATOLOGY, 2010, 2 (03) : 91 - 93
  • [49] Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B
    Konstantinos Tziomalos
    World Journal of Hepatology, 2010, 2 (03) : 91 - 93
  • [50] The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis
    Chen, Xu-Xiao
    Cheng, Jian-Wen
    Huang, Ao
    Zhang, Xin
    Wang, Jian
    Fan, Jia
    Zhou, Jian
    Yang, Xin-Rong
    ONCOTARGETS AND THERAPY, 2017, 10 : 5363 - 5375
12345